Sibel Health is a Health & Biometric Sensing company founded in 2018 and based in Chicago, United States. It has raised $72M in total funding, most recently a Series C in 2025.
| Date | Stage | Amount | Valuation | Lead investors |
|---|---|---|---|---|
| Oct 14, 2025 | Series C extension | $9M | — | — |
| Mar 20, 2025 | Series C | $30M | — | Steele Foundation for Hope, Dräger |
| Aug 4, 2022 | Series B | $33M | — | Steele Foundation for Hope |
No articles ingested yet for Sibel Health. Once the hourly news pipeline is live, every article the classifier tags as mentioning this company appears here with its one-line AI summary and sentiment.
ANNE One is Sibel Health's FDA-cleared wireless monitoring platform built around soft, body-worn sensors. The ANNE Chest sensor tracks heart rate, respiratory rate, ECG, body temperature, posture, step count and fall events, while the ANNE Limb sensor measures SpO2 and skin and body temperature. Data streams to an integrated mobile app and cloud dashboard with AI-enabled analytics, letting clinicians monitor multiple patients' vitals continuously and wirelessly across hospital wards, lower-acuity settings and the home, replacing tethered bedside monitors.
Sibel Health extended its ANNE platform to maternal-fetal monitoring, receiving FDA clearance for a wearable system that wirelessly tracks maternal and fetal vital signs during labor and pregnancy. The wearable sensors capture maternal heart rate, uterine activity and fetal heart rate without the bulky belts and wired transducers of conventional cardiotocography, aiming to make continuous obstetric monitoring more comfortable and deployable in lower-resource and home settings. The system is part of Sibel's broader push to bring hospital-grade continuous monitoring to underserved care environments.
1 patent on file, but none with both an extractable figure and an abstract on Google Patents yet.
We don't have a live feed for this company's ATS. Their careers page has every open role.
View all careers ↗